Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 5
1982 6
1983 8
1984 5
1985 7
1986 3
1987 3
1988 2
1989 6
1990 12
1991 2
1992 6
1993 8
1994 3
1995 4
1996 6
1997 2
1998 4
1999 6
2000 6
2001 4
2002 3
2003 4
2004 9
2005 7
2006 13
2007 15
2008 20
2009 17
2010 20
2011 19
2012 18
2013 17
2014 14
2015 21
2016 13
2017 18
2018 14
2019 7
2020 13
2021 7
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH; Second International Symposium on IgG4-Related Disease. Khosroshahi A, et al. Among authors: shimatsu a. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132. Arthritis Rheumatol. 2015. PMID: 25809420 Review. No abstract available.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. Ito T, et al. Among authors: shimatsu a. J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29. J Gastroenterol. 2021. PMID: 34586495 Free PMC article.
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H. Umehara H, et al. Among authors: shimatsu a. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z. Epub 2012 Jan 5. Mod Rheumatol. 2012. PMID: 22218969
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ, Kim JH, Lacroix A, Laplanche A, O'Connell P, Tauchmanova L, Pedroncelli AM, Biller BMK; LINC 3 investigators. Pivonello R, et al. Among authors: shimatsu a. Lancet Diabetes Endocrinol. 2020 Sep;8(9):748-761. doi: 10.1016/S2213-8587(20)30240-0. Epub 2020 Jul 27. Lancet Diabetes Endocrinol. 2020. PMID: 32730798 Clinical Trial.
[Hypothalamic syndrome].
Shimatsu A. Shimatsu A. Nihon Rinsho. 2006 May 28;Suppl 1:5-7. Nihon Rinsho. 2006. PMID: 16776080 Review. Japanese. No abstract available.
¹⁸F-FDG-PET-positive adrenal tumour.
Kakita-Kobayashi M, Usui T, Sasano H, Shimatsu A. Kakita-Kobayashi M, et al. Among authors: shimatsu a. BMJ Case Rep. 2015 Mar 6;2015:bcr2015209379. doi: 10.1136/bcr-2015-209379. BMJ Case Rep. 2015. PMID: 25750227 Free PMC article. No abstract available.
Hypopituitarism: oddities.
Shimatsu A. Shimatsu A. Horm Res. 2007;68 Suppl 5:137. doi: 10.1159/000110609. Epub 2007 Dec 10. Horm Res. 2007. PMID: 18174731 No abstract available.
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.
Fleseriu M, Newell-Price J, Pivonello R, Shimatsu A, Auchus RJ, Scaroni C, Belaya Z, Feelders RA, Vila G, Houde G, Walia R, Izquierdo M, Roughton M, Pedroncelli AM, Biller BMK. Fleseriu M, et al. Among authors: shimatsu a. Eur J Endocrinol. 2022 Sep 16;187(4):531-541. doi: 10.1530/EJE-22-0317. Print 2022 Oct 1. Eur J Endocrinol. 2022. PMID: 35980235 Free PMC article.
Proposal of diagnostic criteria for IgG4-related thyroid disease.
Takeshima K, Li Y, Kakudo K, Hirokawa M, Nishihara E, Shimatsu A, Takahashi Y, Akamizu T. Takeshima K, et al. Among authors: shimatsu a. Endocr J. 2021 Jan 28;68(1):1-6. doi: 10.1507/endocrj.EJ20-0557. Epub 2020 Dec 12. Endocr J. 2021. PMID: 33311000 Free article. Review.
350 results